Enzymatica AB

Quotes

ColdZyme is the future of cold relief. By breaking the viral cycle at the first signs of symptoms, the product helps cut illness duration in half and speeds up recovery.

Sana Alajmovic

We offer a unique, evidence-based alternative in a market dominated by outdated products. ColdZyme reduces viral load by 94 percent, helping you avoid putting your life on hold.

Sana Alajmovic

My focus is to lead Enzymatica into its next phase of growth. ColdZyme is a consumer favorite with clinically proven efficacy – we have the potential to become a global leader.

Sana Alajmovic

Pick a time period -

Tags ( Active)

All Regulatory Non-Regulatory

Quarterly report Q2/2025: Strong development in Sweden and increased international activity

Thu, Jul 17, 2025 08:30 CET

Second quarter January-June · Net sales · Net sales reached SEK 20.6 (15.8)reached SEK 8.3 million.(6.4) · The operating result totaled SEK -32.9 (million. -31.9) million. · The operating · Earnings per share, basic and diluted,result totaled SEK were SEK -0.13 (-0.19).-14.9 (-13.5) · Cash flow from operating activities formillion. the period totaled SEK -29.9 (-26.3) · Earnings per million.share, basic and diluted, were SEK-0.06 (-0.08). · Cash flow fromoperatingactivities totaled

There are no items matching the current filter

There are no more items matching the current filter

Back to top

Share

Quotes

Quarterly report Q2/2025: Strong development in Sweden and increased international activity

Subscribe